Endosialin/CD248/TEM1 Antibody (OTI4B8) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72075JF669
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # OTI4B8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Endosialin/CD248/TEM1 Antibody (OTI4B8) [Janelia Fluor® 669]
Immunogen
Human recombinant protein fragment corresponding to amino acids 20-300 of human CD248(NP_065137) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Endosialin/CD248/TEM1 Antibody (OTI4B8) [Janelia Fluor® 669]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Endosialin/CD248
Alternate Names
CD164L1, CD248, TEM1
Gene Symbol
CD248
Additional Endosialin/CD248 Products
Product Documents for Endosialin/CD248/TEM1 Antibody (OTI4B8) [Janelia Fluor® 669]
Product Specific Notices for Endosialin/CD248/TEM1 Antibody (OTI4B8) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...